Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

654 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.
Lehky TJ, Levin MC, Kubota R, Bamford RN, Flerlage AN, Soldan SS, Leist TP, Xavier A, White JD, Brown M, Fleisher TA, Top LE, Light S, McFarland HF, Waldmann TA, Jacobson S. Lehky TJ, et al. Among authors: waldmann ta. Ann Neurol. 1998 Dec;44(6):942-7. doi: 10.1002/ana.410440613. Ann Neurol. 1998. PMID: 9851439
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial.
Nussenblatt RB, Fortin E, Schiffman R, Rizzo L, Smith J, Van Veldhuisen P, Sran P, Yaffe A, Goldman CK, Waldmann TA, Whitcup SM. Nussenblatt RB, et al. Among authors: waldmann ta. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7462-6. doi: 10.1073/pnas.96.13.7462. Proc Natl Acad Sci U S A. 1999. PMID: 10377437 Free PMC article. Clinical Trial.
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta.
Bielekova B, Richert N, Howard T, Blevins G, Markovic-Plese S, McCartin J, Frank JA, Würfel J, Ohayon J, Waldmann TA, McFarland HF, Martin R. Bielekova B, et al. Among authors: waldmann ta. Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8705-8. doi: 10.1073/pnas.0402653101. Epub 2004 May 25. Proc Natl Acad Sci U S A. 2004. PMID: 15161974 Free PMC article. Clinical Trial.
Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, Waldmann TA, McFarland H, Henkart PA, Martin R. Bielekova B, et al. Among authors: waldmann ta. Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5941-6. doi: 10.1073/pnas.0601335103. Epub 2006 Apr 3. Proc Natl Acad Sci U S A. 2006. PMID: 16585503 Free PMC article. Clinical Trial.
654 results